Chinese Biotechs Join COVID-19 Treatment Race With Repurposed Cancer Drugs

 
• By Dexter Jie Yan
  
China COVID antiAndrogen drugs
Second-Only Chinese Biotech Joins The Hunt For COVID-19 Cure With a Me-Too of Xtandi • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia